Literature DB >> 28289005

Thrombolytic Therapy Targeting Alpha 2-Antiplasmin.

Tetsumei Urano1, Yuko Suzuki2.   

Abstract

Entities:  

Keywords:  Editorials; plasminogen activator; pulmonary embolism; thrombolysis

Mesh：

Substances：

Year:  2017        PMID： 28289005     DOI： 10.1161/CIRCULATIONAHA.117.026884

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Assessment of histological characteristics, imaging markers, and rt-PA susceptibility of ex vivo venous thrombi.

Authors:  Samuel A Hendley; Alexey Dimov; Aarushi Bhargava; Erin Snoddy; Daniel Mansour; Rana O Afifi; Geoffrey D Wool; Yuanyuan Zha; Steffen Sammet; Zheng Feng Lu; Osman Ahmed; Jonathan D Paul; Kenneth B Bader
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

Review 2.  Regulation of plasminogen activation on cell surfaces and fibrin.

Authors:  T Urano; F J Castellino; Y Suzuki
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

3.  Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism.

Authors:  Iman Darwish; Jawed Fareed; Yevgeniy Brailovsky; Debra Hoppensteadt; Brett Slajus; Emily Bontekoe; Frank De Stefano; Trent Reed; Amir Darki
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.